Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Rare rheumatology disease in spotlight after Sanofi, Regeneron nab first drug approval, more in pipeline potentials
3 years ago
Pharma
Marketing
InflaRx plans to launch Covid antibody with five-figure price tag
3 years ago
Pharma
FDA+
Genentech notches ‘steady progress’ on latest diversity and inclusion report card
3 years ago
Pharma
Marketing
Sanofi breaks ground on BARDA-backed, $160M vaccine manufacturing site in Pennsylvania
3 years ago
Pharma
Manufacturing
Amgen's denosumab shows promise in small, NIH-funded rare bone disease study
3 years ago
R&D
FDA closes out series of patient-focused drug development guidance
3 years ago
FDA+
Incyte links arms with tiny Biotheryx for protein degrader deal, targeting cancer
3 years ago
Deals
R&D
Ginkgo snaps up gene therapy vector assets from StrideBio
3 years ago
Deals
R&D
Hedge fund slams Exelixis for R&D management, launches proxy fight for board seats (updated)
3 years ago
People
PureTech wants to buy back its weight loss pill spinout after lackluster SPAC
3 years ago
People
Deals
'Have to keep up this pace': As new Vir CEO, Marianne De Backer eyes expansion beyond infectious disease
3 years ago
People
AstraZeneca's Lynparza-Imfinzi combo clears PhIII trial in ovarian cancer
3 years ago
R&D
J&J spinout files second bankruptcy attempt in $8.9B bid to settle talc lawsuits
3 years ago
Pharma
Law
Estée Lauder's family injects $200M into Alzheimer’s Drug Discovery Foundation
3 years ago
R&D
Following clinical setbacks, NGM Bio lays off 33% of staffers as founder departs
3 years ago
People
Proxygen and Merck strike license deal worth up to $2.55B for protein degradation
3 years ago
Startups
Deals
InflaRx wins FDA emergency use authorization for Covid antibody
3 years ago
Pharma
FDA+
Pfizer accused of Covid-19 vaccine patent infringement again, this time by Arbutus and Genevant
3 years ago
Pharma
Law
J&J’s Janssen takes doctors ‘beyond the textbook’ to teach about psoriasis in people of color
3 years ago
Pharma
Marketing
Thermo Fisher set to shutter a site in New Jersey, lay off 100+ people
3 years ago
People
Pharma
FDA requires opioid manufacturers to provide mail-back disposal option
3 years ago
Pharma
FDA+
Delaware court dismisses Merck's talc liability suit against Bayer
3 years ago
Pharma
Law
Akebia touts new data on anemia drug a year after rejection
3 years ago
R&D
Pharma
MarketingRx roundup: Pfizer leaders join speaker lineup at Cannes ad fest; Jazz reups sleep sponsorship
3 years ago
Pharma
Marketing
First page
Previous page
362
363
364
365
366
367
368
Next page
Last page